Nagoya

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Endometrial cancer1 trial
• Head and neck cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Eisai Co., Ltd.1 trial
• Eisai Inc.1 trial

Closed trials

• Completed

  Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

  NCT03517449· Phase 3· Eisai Inc.· Source

• Terminated

  A Study of E7130 in Participants With Solid Tumors

  NCT03444701· Phase 1· Eisai Co., Ltd.· Source